In this rich article, Advarra’s James Riddle discusses the possibilities for AI in clinical research, how IRBs should review trials with an AI component, and an overview of the AI landscape relative to clinical research.
In this rich article, Advarra’s James Riddle discusses the possibilities for AI in clinical research, how IRBs should review trials with an AI component, and an overview of the AI landscape relative to clinical research.